Jaguar Health (JAGX) Net Cash Flow (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Net Cash Flow data on file, last reported at $2.2 million in Q1 2026.

• On a quarterly basis, Net Cash Flow rose 194.34% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $4.6 million, a 176.43% increase from a year earlier, with the FY2025 full-year figure at -$57000.0, down 103.59% from the prior year.
• Net Cash Flow for Q1 2026 stood at $2.2 million, down from $4.3 million in the prior quarter.
• Over the last five years, Net Cash Flow for JAGX reached as high as $8.9 million in Q1 2023 and fell as low as -$7.2 million in Q2 2022.
• Historically, Net Cash Flow has averaged -$325882.4 across 5 years, with a median of $455000.0 in 2022.
• Across the five-year window, Net Cash Flow tumbled 2071.99% in 2022 and jumped 1848.57% in 2023, its largest moves.
• Year by year, Net Cash Flow stood at -$5.1 million in 2022, then jumped by 162.16% to $3.2 million in 2023, then sank by 262.89% to -$5.2 million in 2024, then soared by 182.81% to $4.3 million in 2025, then plunged by 48.67% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $2.2 million in Q1 2026, $4.3 million in Q4 2025, and $1.6 million in Q3 2025.